Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleSpecial Section – New Models in Drug Metabolism and Transport
Open Access

Fabrication of a Corneal Model Composed of Corneal Epithelial and Endothelial Cells via a Collagen Vitrigel Membrane Functioned as an Acellular Stroma and Its Application to the Corneal Permeability Test of Chemicals

Hiroyuki Yamaguchi and Toshiaki Takezawa
Drug Metabolism and Disposition November 2018, 46 (11) 1684-1691; DOI: https://doi.org/10.1124/dmd.118.080820
Hiroyuki Yamaguchi
Division of Biotechnology, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, Ibaraki, Japan (H.Y., T.T.); and Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Isehara, Kanagawa, Japan (H.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiaki Takezawa
Division of Biotechnology, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, Ibaraki, Japan (H.Y., T.T.); and Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Isehara, Kanagawa, Japan (H.Y.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Schematic illustration of six corneal models using chambers with thin and thick CVM scaffolds. BM model (A), CEpi model (B), CEpi-Endo model (C), AS model (D), CEpi-AS model (E), and CEpi-AS-Endo model (F). Black lines represent plastic cylinders and hangers of a CVM chamber.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Phase-contrast microscopic observations of BCD C/D-1b cells. BCD C/D-1b cells before cloning (A) and endothelial cell–like clonal cells at passage numbers 1 (B) and 28 (C) after cloning were cultured in a tissue culture plate. Scale bar, 50 μm.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Microscopic observations of a corneal endothelial layer in a CVM camber. The endothelial cell–like clonal cells from BCD C/D-1b cells were cultured for 1 day (A, D, and G), 3 days (B, E, and H), and 7 days (C, F, and I). The clonal cells were observed with a phase-contrast microscope (A–C), and were stained with antibodies for Na+-K+ ATPase (D–F) and ZO-1 (G–I). The nuclei of cells were counterstained with Hoechst 33342 (D–I). Scale bar, 50 μm.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Time-dependent change of TEER-end values of a corneal endothelial layer in a CVM camber. Each value represents the mean ± S.D. (n = 3). *P < 0.05.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Microscopic observations of a CEpi-AS model. Cross sections of the model were stained with hematoxylin and eosin (A and B) and were also stained with antibodies for ZO-1 (C), occludin (D), connexin-43 (E), cytokeratin 3 (F), and MUC1 (G). The nuclei of cells were counterstained with Hoechst 33342 (C–G). Scale bar, 50 μm.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Microscopic observations of corneal models composed of corneal epithelial cells and endothelial cells via a CVM. Cross sections of the CEpi-Endo model (A) and the CEpi-AS-Endo model (B) were stained with hematoxylin and eosin. Scale bar, 50 μm.

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Comparison among the permeability coefficient of a BM model (A), that of an AS model (B), and that of a commercially available multiporous PET membrane (C). Each permeability coefficient was tested using cyanocobalamin, FD4, FD10, FD20, and FD40. Dashed lines represent slopes calculated by least-squares test. Each value represents the mean ± S.D. (n = 3).

  • Fig. 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Comparison between the permeability coefficient of FD-4 (A) and FD-10 (B) in each corneal model reconstructed in the CVM chamber described in Table 1 and that in an excised rabbit cornea. Each value represents the mean ± S.D. (n = 3). *P < 0.1; **P < 0.05; ***P < 0.01; ****P < 0.001.

Tables

  • Figures
    • View popup
    TABLE 1

    Permeability coefficient of six corneal models

    Each value represents the mean ± S.D. of three independent experiments.

    Type of ModelPermeability Coefficient
    CyanocobalaminFD-4FD-10FD-20FD-40
    ×10−6 cm/s
    Acellular modelBM9.38 ± 0.474.22 ± 0.181.20 ± 0.310.46 ± 0.060.12 ± 0.002
    AS4.45 ± 0.321.46 ± 0.140.81 ± 0.110.24 ± 0.030.17 ± 0.03
    Culture modelCEpi0.82 ± 0.0970.36 ± 0.010.31 ± 0.020.36 ± 0.060.054 ± 0.01
    CEpi-EndoNot detected0.25 ± 0.040.13 ± 0.020.084 ± 0.010.050 ± 0.01
    CEpi-ASNot detected0.14 ± 0.060.046 ± 0.070.009 ± 0.0020.017 ± 0.009
    CEpi-AS -EndoNot detected0.033 ± 0.020.019 ± 0.010.016 ± 0.0050.033 ± 0.028
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 46 (11)
Drug Metabolism and Disposition
Vol. 46, Issue 11
1 Nov 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Fabrication of a Corneal Model Composed of Corneal Epithelial and Endothelial Cells via a Collagen Vitrigel Membrane Functioned as an Acellular Stroma and Its Application to the Corneal Permeability Test of Chemicals
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleSpecial Section – New Models in Drug Metabolism and Transport

Corneal Model Useful for the Permeability Test of Chemicals

Hiroyuki Yamaguchi and Toshiaki Takezawa
Drug Metabolism and Disposition November 1, 2018, 46 (11) 1684-1691; DOI: https://doi.org/10.1124/dmd.118.080820

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleSpecial Section – New Models in Drug Metabolism and Transport

Corneal Model Useful for the Permeability Test of Chemicals

Hiroyuki Yamaguchi and Toshiaki Takezawa
Drug Metabolism and Disposition November 1, 2018, 46 (11) 1684-1691; DOI: https://doi.org/10.1124/dmd.118.080820
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A Practical Guide to Pharmacomicrobiomics
  • Characterization of P-Glycoprotein Humanized Mice
  • Pheophorbide A: In Vivo Probe of ABCG2 Function/Inhibition
Show more Special Section – New Models in Drug Metabolism and Transport

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics